Development of unique advanced hemp-based skincare treatment formulations, dermatological and cosmetic beauty products.
The 50% owned joint venture with Pharmocann is developing a premium range of 100% plant-based skincare products. It is anticipated that the current three month trial phase will be followed by large scale production. The products will be made available for sale in Australia and for export to Asia and other international markets.
Cann Global continues to formalise the brand strategy and position, and go to market plans to ensure a differentiated premium product offering for consumers.
More information coming soon – Watch this space!